We found 10 episodes of Oncology Today with Dr Neil Love with the tag “immunotherapy”.
-
PARP Inhibitors in Breast Cancer Edition
September 23rd, 2020 | 58 mins 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the use of PARP inhibitors in breast cancer with Dr Susan Domchek, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
September 21st, 2020 | 41 mins 38 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the treatment of myeloproliferative neoplasms with Dr Srdan Verstovsek, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition
September 17th, 2020 | 51 mins 47 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, mutations, oncology, oncology education, research to practice, telemedicine
Featuring a discussion on recent advances in the treatment of EGFR mutation-positive non-small cell lung cancer with Dr Pasi Jänne, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition
September 15th, 2020 | 42 mins 53 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, multiple myeloma, oncology, oncology education, research to practice
For this special edition of Oncology Today, I met with Dr Nikhil Munshi from the Dana-Farber Cancer Institute in Boston to discuss recently published and emerging research on the use of CAR T-cell therapy in multiple myeloma.
-
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
September 11th, 2020 | 46 mins 35 secs
bladder cancer, cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a discussion on recent advances in the use of immunotherapy for urothelial bladder cancer with Dr Petros Grivas, moderated by Neil Love, MD.
-
Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition
September 4th, 2020 | 39 mins 39 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, oncology, oncology education, research to practice, skin cancer
For this special edition of Oncology Today, I met with Dr Nikhil Khushalani from Moffitt Cancer Center to discuss recent data and optimal management of cutaneous squamous cell carcinoma.
-
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition
August 28th, 2020 | 45 mins 25 secs
cancer, cancer treatment, chemotherapy, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
For this special edition of Oncology Today, I met with Dr Charles Rudin from Memorial Sloan Kettering Cancer Center in New York to discuss recently published and emerging research in the management of small cell lung cancer.
-
Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard
August 18th, 2020 | 1 hr 26 mins
cancer, cancer treatment, chemotherapy, dr neil love, follicular lymphoma, immunotherapy, oncology, oncology education, research to practice
Featuring a roundtable discussion on recent data and optimal management of follicular lymphoma with Drs Carla Casulo and John P Leonard moderated by Neil Love, MD.
-
Oncology Today Special Roundtable: Colorectal Cancer
August 5th, 2020 | 1 hr 30 mins
cancer, cancer treatment, chemotherapy, colorectal cancer, dr neil love, immunotherapy, oncology, oncology education, research to practice
Featuring a roundtable discussion with Drs Axel Grothey and Michael J Overman moderated by Neil Love, MD.
-
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson
August 1st, 2020 | 15 mins 34 secs
cancer, cancer treatment, chemotherapy, coronavirus, covid 19, covid-19, dr neil love, immunotherapy, lung cancer, oncology, oncology education, research to practice, telemedicine
Dr John Heymach from the MD Anderson Cancer Center discusses the role of anti-angiogenic agents in NSCLC and the status of clinical research for and treatment of lung cancer at MD Anderson during the COVID-19 pandemic.